Anterior Approach vs Conventional Hepatectomy for ...
文章推薦指數: 80 %
Importance Tumor relapse after partial hepatectomy for colorectal liver metastasis (CRLM) remains an unsolved issue. Intraoperative manipulation ... AnteriorApproachvsConventionalHepatectomyforResectionofColorectalLiverMetastasis:ARandomizedClinicalTrial|ColorectalCancer|JAMASurgery|JAMANetwork Ourwebsiteusescookiestoenhanceyourexperience.Bycontinuingtouseoursite,orclicking"Continue,"youareagreeingtoourCookiePolicy | Continue [SkiptoNavigation] fulltexticon FullText contentsicon Contents figureicon Figures/Tables multimediaicon Multimedia attachicon SupplementalContent referencesicon References relatedicon Related commentsicon Comments DownloadPDF Comment TopofArticle KeyPoints Abstract Introduction Methods Results Discussion Conclusions ArticleInformation References Figure1. CONSORTDiagramViewLargeDownloadaOnepatienthadapositiveresectionmarginandbloodlossexceeding2000mLsimultaneously.bTwopatientshadpositiveresectionmargins,bloodlossexceeding2000mL,andpreoperativepositivetumorcellssimultaneously.Figure2. Kaplan-MeierPlotsforOverallandDisease-FreeSurvivalViewLargeDownloadThegraphsdepictKaplan-Meierestimatedoverallsurvival(A)anddisease-freesurvival(B)stratifiedbyanteriorapproachvsconventionalhepatectomy(log-ranktest)andKaplan-Meierestimatedoverallsurvival(C)anddisease-freesurvival(D)stratifiedbyperioperativepositiveandnegativefindingsforcirculatingtumorcells(CTC)(log-ranktest). Table1. BaselineCharacteristicsViewLargeDownloadTable2. OperativeDetailsandPerioperativeOutcomesViewLargeDownloadTable3. OncologicalOutcomesViewLargeDownload Supplement1.TrialProtocol Supplement2.eTable1.TumorCellDetectioninBloodSampleseTable2.ComparisonofTumorCellDetectioninBloodandBoneMarrowSampleseTable3.CoxRegressionAnalysis Supplement3.DataSharingStatement 1.Creasy JM,Sadot E,Koerkamp BG, etal. Actual10-yearsurvivalafterhepaticresectionofcolorectallivermetastases:whatfactorsprecludecure? Surgery.2018;163(6):1238-1244.doi:10.1016/j.surg.2018.01.004PubMedGoogleScholarCrossref2.deJong MC,Mayo SC,Pulitano C, etal. Repeatcurativeintentliversurgeryissafeandeffectiveforrecurrentcolorectallivermetastasis:resultsfromaninternationalmulti-institutionalanalysis. JGastrointestSurg.2009;13(12):2141-2151.doi:10.1007/s11605-009-1050-0PubMedGoogleScholarCrossref3.deJong MC,Pulitano C,Ribero D, etal. Ratesandpatternsofrecurrencefollowingcurativeintentsurgeryforcolorectallivermetastasis:aninternationalmulti-institutionalanalysisof1669patients. AnnSurg.2009;250(3):440-448.doi:10.1097/SLA.0b013e3181b4539bPubMedGoogleScholarCrossref4.Rahbari NN,D’Angelica MI. Surgicalsalvageofrecurrenceafterresectionofcolorectallivermetastases:incidenceandoutcomes. HepatOncol.2017;4(1):25-33.doi:10.2217/hep-2017-0002PubMedGoogleScholar5.Bork U,Rahbari NN,Schölch S, etal. Circulatingtumourcellsandoutcomeinnon-metastaticcolorectalcancer:aprospectivestudy. BrJCancer.2015;112(8):1306-1313.doi:10.1038/bjc.2015.88PubMedGoogleScholarCrossref6.GrootKoerkamp B,Rahbari NN,Büchler MW,Koch M,Weitz J. Circulatingtumorcellsandprognosisofpatientswithresectablecolorectallivermetastasesorwidespreadmetastaticcolorectalcancer:ameta-analysis. AnnSurgOncol.2013;20(7):2156-2165.doi:10.1245/s10434-013-2907-8PubMedGoogleScholarCrossref7.Rahbari NN,Aigner M,Thorlund K, etal. Meta-analysisshowsthatdetectionofcirculatingtumorcellsindicatespoorprognosisinpatientswithcolorectalcancer. Gastroenterology.2010;138(5):1714-1726.doi:10.1053/j.gastro.2010.01.008PubMedGoogleScholarCrossref8.Rahbari NN,Bork U,Schölch S, etal. Metastaticspreademergingfromlivermetastasesofcolorectalcancer:doestheseedleavethesoilagain? AnnSurg.2016;263(2):345-352.doi:10.1097/SLA.0000000000001341PubMedGoogleScholarCrossref9.Iwatsuki S,Esquivel CO,Gordon RD,Starzl TE. Liverresectionformetastaticcolorectalcancer. Surgery.1986;100(4):804-810.PubMedGoogleScholar10.Weitz J,Koch M,Kienle P, etal. Detectionofhematogenictumorcelldisseminationinpatientsundergoingresectionoflivermetastasesofcolorectalcancer. AnnSurg.2000;232(1):66-72.doi:10.1097/00000658-200007000-00010PubMedGoogleScholarCrossref11.Hao S,Chen S,Tu C,Huang T. AnteriorapproachtoimprovetheprognosisinHCCpatientsviadecreasingdisseminationofEpCAM+circulatingtumorcells. JGastrointestSurg.2017;21(7):1112-1120.doi:10.1007/s11605-017-3410-5PubMedGoogleScholarCrossref12.Liu CL,Fan ST,Cheung ST,Lo CM,Ng IO,Wong J. Anteriorapproachversusconventionalapproachrighthepaticresectionforlargehepatocellularcarcinoma:aprospectiverandomizedcontrolledstudy. AnnSurg.2006;244(2):194-203.doi:10.1097/01.sla.0000225095.18754.45PubMedGoogleScholarCrossref13.Schmidt T,Koch M,Antolovic D, etal. Influenceoftwodifferentresectiontechniques(conventionalliverresectionversusanteriorapproach)oflivermetastasesfromcolorectalcanceronhematogenoustumorcelldissemination:prospectiverandomizedmulticentertrial. BMCSurg.2008;8:6.doi:10.1186/1471-2482-8-6PubMedGoogleScholarCrossref14.Weitz J,Kienle P,Magener A, etal. Detectionofdisseminatedcolorectalcancercellsinlymphnodes,bloodandbonemarrow. ClinCancerRes.1999;5(7):1830-1836.PubMedGoogleScholar15.Ozawa K. NonconventionalApproachestoAdvancedLiverCancer:LiverSurgeryApproachedThroughtheMitochondria.MedicalTribune;1992:117-165.16.Liddo G,Buc E,Nagarajan G,Hidaka M,Dokmak S,Belghiti J. Theliverhangingmanoeuvre. HPB(Oxford).2009;11(4):296-305.doi:10.1111/j.1477-2574.2009.00068.xPubMedGoogleScholarCrossref17.Li Y,Xu KS,Li JS, etal. Theresearchofno-touchisolationtechniqueonthepreventionofpostoperativerecurrenceandmetastasisofhepatocellularcarcinomaafterhepatectomy. Hepatogastroenterology.2014;61(131):784-791.PubMedGoogleScholar18.Arrazubi V,Mata E,Antelo ML, etal. Circulatingtumorcellsinpatientsundergoingresectionofcolorectalcancerlivermetastases:clinicalutilityforlong-termoutcome:aprospectivetrial. AnnSurgOncol.2019;26(9):2805-2811.doi:10.1245/s10434-019-07503-8PubMedGoogleScholarCrossref19.Seeberg LT,Waage A,Brunborg C, etal. Circulatingtumorcellsinpatientswithcolorectallivermetastasispredictimpairedsurvival. AnnSurg.2015;261(1):164-171.doi:10.1097/SLA.0000000000000580PubMedGoogleScholarCrossref20.Gasch C,Bauernhofer T,Pichler M, etal. HeterogeneityofepidermalgrowthfactorreceptorstatusandmutationsofKRAS/PIK3CAincirculatingtumorcellsofpatientswithcolorectalcancer. ClinChem.2013;59(1):252-260.doi:10.1373/clinchem.2012.188557PubMedGoogleScholarCrossref21.Mostert B,Jiang Y,Sieuwerts AM, etal. KRASandBRAFmutationstatusincirculatingcolorectaltumorcellsandtheircorrelationwithprimaryandmetastatictumortissue. IntJCancer.2013;133(1):130-141.doi:10.1002/ijc.27987PubMedGoogleScholarCrossref22.Soler A,Cayrefourcq L,Mazard T, etal. Autologouscelllinesfromcirculatingcoloncancercellscapturedfromsequentialliquidbiopsiesasmodeltostudytherapy-driventumorchanges. SciRep.2018;8(1):15931.doi:10.1038/s41598-018-34365-zPubMedGoogleScholarCrossref23.She WH,Chan ACY,Ma KW, etal. Anteriorapproachtomajorresectionforcolorectallivermetastasis. JGastrointestSurg.2018;22(11):1928-1938.doi:10.1007/s11605-018-3840-8PubMedGoogleScholarCrossref24.Llado L,Muñoz A,Ramos E,Torras J,Fabregat J,Rafecas A. Theanteriorhanging-approachimprovespostoperativecourseafterrighthepatectomyinpatientswithcolorectallivermetastases:resultsofaprospectivestudywithpropensity-scorematchingcomparison. EurJSurgOncol.2016;42(2):176-183.doi:10.1016/j.ejso.2015.11.009PubMedGoogleScholarCrossref25.Fritzmann J,Kirchberg J,Sturm D, etal. RandomizedclinicaltrialofstaplerhepatectomyversusLigaSure™transectioninelectivehepaticresection. BrJSurg.2018;105(9):1119-1127.doi:10.1002/bjs.10902PubMedGoogleScholarCrossref26.Fretland AA,Dagenborg VJ,Bjørnelv GMW, etal. Laparoscopicversusopenresectionforcolorectallivermetastases:theOSLO-COMETrandomizedcontrolledtrial. AnnSurg.2018;267(2):199-207.doi:10.1097/SLA.0000000000002353PubMedGoogleScholarCrossref27.Schnitzbauer AA,Lang SA,Goessmann H, etal. Rightportalveinligationcombinedwithinsitusplittinginducesrapidleftlateralliverlobehypertrophyenabling2-stagedextendedrighthepaticresectioninsmall-for-sizesettings. AnnSurg.2012;255(3):405-414.doi:10.1097/SLA.0b013e31824856f5PubMedGoogleScholarCrossref28.Capussotti L,Ferrero A,Russolillo N,Langella S,LoTesoriere R,Viganò L. Routineanteriorapproachduringrighthepatectomy:resultsofaprospectiverandomisedcontrolledtrial. JGastrointestSurg.2012;16(7):1324-1332.doi:10.1007/s11605-012-1894-6PubMedGoogleScholarCrossref29.Coppa J,Citterio D,Cotsoglou C, etal. Transhepaticanteriorapproachtotheinferiorvenacavainlargeretroperitonealtumorsresectedenblocwiththerightliverlobe. Surgery.2013;154(5):1061-1068.doi:10.1016/j.surg.2013.05.027PubMedGoogleScholarCrossref30.Hinz S,Hendricks A,Wittig A, etal. DetectionofcirculatingtumorcellswithCK20RT-PCRisanindependentnegativeprognosticmarkerincoloncancerpatients:aprospectivestudy. BMCCancer.2017;17(1):53.doi:10.1186/s12885-016-3035-1PubMedGoogleScholarCrossref31.Koch M,Kienle P,Hinz U, etal. Detectionofhematogenoustumorcelldisseminationpredictstumorrelapseinpatientsundergoingsurgicalresectionofcolorectallivermetastases. AnnSurg.2005;241(2):199-205.doi:10.1097/01.sla.0000151795.15068.27PubMedGoogleScholarCrossref32.Soeth E,Vogel I,Röder C, etal. ComparativeanalysisofbonemarrowandvenousbloodisolatesfromgastrointestinalcancerpatientsforthedetectionofdisseminatedtumorcellsusingreversetranscriptionPCR. CancerRes.1997;57(15):3106-3110.PubMedGoogleScholar ARandomizedClinicalTrialonAnteriorApproachvsConventionalHepatectomy—ToTerminateorNottoTerminatetheStudy Comment&Response September1,2021 Divya Gupta, MD;J.Jack Lee, PhD;AlbertY. Lin, MD,MPH ErrorsinText,Table,andFigure Correction September1,2021 NonsuperiorityoftheAnteriorApproachtoConventionalHepatectomyforResectionofColorectalLiverMetastasis InvitedCommentary January1,2021 Iswanto Sucandy, MD;Allan Tsung, MD SeeMoreAbout HepatobiliarySurgeryOncologySurgicalOncologyGastrointestinalSurgeryColorectalCancerGastroenterologyGastroenterologyandHepatologyGastrointestinalCancerSurgery SelectYourInterests SelectYourInterests CustomizeyourJAMANetworkexperiencebyselectingoneormoretopicsfromthelistbelow. AcidBase,Electrolytes,Fluids AddictionMedicine AllergyandClinicalImmunology Anesthesiology Anticoagulation ArtandImagesinPsychiatry BleedingandTransfusion Cardiology CaringfortheCriticallyIllPatient ChallengesinClinicalElectrocardiography ClinicalChallenge ClinicalDecisionSupport ClinicalImplicationsofBasicNeuroscience ClinicalPharmacyandPharmacology ComplementaryandAlternativeMedicine ConsensusStatements Coronavirus(COVID-19) CriticalCareMedicine CulturalCompetency DentalMedicine Dermatology DiabetesandEndocrinology DiagnosticTestInterpretation Diversity,Equity,andInclusion DrugDevelopment ElectronicHealthRecords EmergencyMedicine EndofLife EnvironmentalHealth Ethics FacialPlasticSurgery GastroenterologyandHepatology GeneticsandGenomics GenomicsandPrecisionHealth Geriatrics GlobalHealth GuidetoStatisticsandMedicine Guidelines HairDisorders HealthCareDeliveryModels HealthCareEconomics,Insurance,Payment HealthCareQuality HealthCareReform HealthCareSafety HealthCareWorkforce HealthDisparities HealthInequities HealthInformatics HealthPolicy Hematology HistoryofMedicine Humanities Hypertension ImagesinNeurology ImplementationScience InfectiousDiseases InnovationsinHealthCareDelivery JAMAInfographic LawandMedicine LeadingChange LessisMore LGBTQ LifestyleBehaviors MedicalCoding MedicalDevicesandEquipment MedicalEducation MedicalEducationandTraining MedicalJournalsandPublishing Melanoma MobileHealthandTelemedicine NarrativeMedicine Nephrology Neurology NeuroscienceandPsychiatry NotableNotes Nursing Nutrition Nutrition,Obesity,Exercise Obesity ObstetricsandGynecology OccupationalHealth Oncology OphthalmicImages Ophthalmology Orthopedics Otolaryngology PainMedicine PathologyandLaboratoryMedicine PatientCare PatientInformation Pediatrics PerformanceImprovement PerformanceMeasures PerioperativeCareandConsultation Pharmacoeconomics Pharmacoepidemiology Pharmacogenetics PharmacyandClinicalPharmacology PhysicalMedicineandRehabilitation PhysicalTherapy PhysicianLeadership Poetry PopulationHealth PreventiveMedicine ProfessionalWell-being Professionalism PsychiatryandBehavioralHealth PublicHealth PulmonaryMedicine Radiology RegulatoryAgencies Research,Methods,Statistics Resuscitation Rheumatology RiskManagement ScientificDiscoveryandtheFutureofMedicine SharedDecisionMakingandCommunication SleepMedicine SportsMedicine StemCellTransplantation Surgery SurgicalInnovation SurgicalPearls TeachableMoment TechnologyandFinance TheArtofJAMA TheArtsandMedicine TheRationalClinicalExamination Tobaccoande-Cigarettes Toxicology TraumaandInjury TreatmentAdherence Ultrasonography Urology Users'GuidetotheMedicalLiterature Vaccination VenousThromboembolism VeteransHealth Violence Women'sHealth WorkflowandProcess WoundCare,Infection,Healing SavePreferences PrivacyPolicy|TermsofUse OthersAlsoLiked Comment Limit200characters Limit25characters ConflictsofInterestDisclosure Identifyallpotentialconflictsofinterestthatmightberelevanttoyourcomment. Conflictsofinterestcomprisefinancialinterests,activities,andrelationshipswithinthepast3yearsincludingbutnotlimitedtoemployment,affiliation,grantsorfunding,consultancies,honorariaorpayment,speaker'sbureaus,stockownershiporoptions,experttestimony,royalties,donationofmedicalequipment,orpatentsplanned,pending,orissued. Erronthesideoffulldisclosure. Ifyouhavenoconflictsofinterest,check"Nopotentialconflictsofinterest"intheboxbelow.Theinformationwillbepostedwithyourresponse. Notallsubmittedcommentsarepublished.Pleaseseeourcommentingpolicyfordetails. Yes,Ihavepotentialconflictsofinterest. No,Idonothavepotentialconflictsofinterest. Limit140characters Limit3600charactersorapproximately600words Submit Thefollowinginformationisrequiredandmustbecompletedinordertosubmitacomment: ThankYou. Yourcommentsubmissionwassuccessful. Pleaseallowupto2businessdaysforreview,approval,andposting. ViewCorrection ThisIssue Views 3,531 Citations 12 ViewMetrics DownloadPDF Twitter Facebook More LinkedIn CME&MOC Cite This Citation RahbariNN,BirginE,BorkU,MehrabiA,ReißfelderC,WeitzJ.AnteriorApproachvsConventionalHepatectomyforResectionofColorectalLiverMetastasis:ARandomizedClinicalTrial.JAMASurg.2021;156(1):31–40.doi:10.1001/jamasurg.2020.5050 Downloadcitationfile: Ris(Zotero) EndNote BibTex Medlars ProCite RefWorks ReferenceManager Mendeley ©2022 Permissions OriginalInvestigation November4,2020 AnteriorApproachvsConventionalHepatectomyforResectionofColorectalLiverMetastasis:ARandomizedClinicalTrial NuhN. Rahbari, MD1,2;Emrullah Birgin, MD3;Ulrich Bork, MD4;etal Arianeb Mehrabi, MD1;Christoph Reißfelder, MD1,2;Jürgen Weitz, MD4 AuthorAffiliations ArticleInformation 1DepartmentofGeneral,VisceralandTransplantationSurgery,UniversityofHeidelberg,Heidelberg,Germany 2nowaffiliatedwithDepartmentofSurgery,UniversitätsmedizinMannheim,MedicalFacultyMannheim,HeidelbergUniversity,Mannheim,Germany 3DepartmentofSurgery,UniversitätsmedizinMannheim,MedicalFacultyMannheim,HeidelbergUniversity,Mannheim,Germany 4DepartmentofGastrointestinal,ThoracicandVascularSurgery,UniversityHospitalCarlGustavCarusattheTechnischeUniversitätDresden,Dresden,Germany JAMASurg.2021;156(1):31-40.doi:10.1001/jamasurg.2020.5050 visualabstracticon VisualAbstract editorialcommenticon EditorialComment relatedarticlesicon RelatedArticles authorinterviewicon Interviews multimediaicon Multimedia InvitedCommentary NonsuperiorityoftheAnteriorApproachtoConventionalHepatectomyforResectionofColorectalLiverMetastasis Iswanto Sucandy, MD;Allan Tsung, MD Comment&Response ARandomizedClinicalTrialonAnteriorApproachvsConventionalHepatectomy—ToTerminateorNottoTerminatetheStudy Divya Gupta, MD;J.Jack Lee, PhD;AlbertY. Lin, MD,MPH Correction ErrorsinText,Table,andFigure KeyPointsQuestion Doesanteriorapproachhepatectomyreducetumorcelldisseminationduringresectionofcolorectallivermetastasiscomparedwithconventionalhepatectomy?Findings Inthisrandomizedclinicaltrialincluding80participants,nostatisticallysignificantdifferenceintumorcelldissemination(5of21[24%]vs6of22[27%])andoverall(median,73vs55months)anddisease-free(median,48vs40months)survivalwasfoundbetweenconventionalhepatectomyandtheanteriorapproach.Meaning Thesefindingssuggestthatbothtechniquesoffersafeandcomparablepostoperativeandsurvivaloutcomesinpatientsundergoingright-sidedhepatectomyforcolorectalcancer. Abstract Importance Tumorrelapseafterpartialhepatectomyforcolorectallivermetastasis(CRLM)remainsanunsolvedissue.Intraoperativemanipulationoftheliverduringconventionalhepatectomymightenhancehematogenoustumorcellspread.Theanteriorapproachisanalternativeapproachthatmayreduceintraoperativetumorcelldissemination.Objective TodeterminetheefficacyandsafetyoftheanteriorapproachcomparedwithconventionalhepatectomyinpatientsundergoingresectionforCRLM.Design,Setting,andParticipants ThisrandomizedclinicalstudyevaluatedtheefficacyandsafetyoftheanteriorapproachcomparedwithconventionalhepatectomyinadultpatientswithCRLMwhowerescheduledforhepatectomyfromFebruary1,2003,toMarch31,2012,atatertiary-carehospital.Atotalof80patientswithCRLMwererandomizedtotheanteriorapproachandconventionalhepatectomygroupsina1:1ratio.Bonemarrowandbloodsampleswereanalyzedfordisseminatedtumorcellsandcirculatingtumorcells(CTC)usingcytokeratin20reversetranscriptase–polymerasechainreactionanalysis.DatawereanalyzedfromApril1toDecember1,2018,usingintentiontotreat.Interventions Anteriorapproachvsconventionalhepatectomy.MainOutcomesandMeasures TheprimaryendpointwasintraoperativeCTCdetectionincentralbloodsamplesafterliverresection.Secondaryendpointsincludedpostoperativemorbidity,mortality,andlong-termsurvival.Results Amongthe80patientsincludedintheanalysis(48men[60%];mean[SD]age,61[10]years),baselinecharacteristics,includingpreoperativeCTCdetection,werecomparablebetweenbothgroups.TherewasnostatisticallysignificantdifferenceinintraoperativeCTCdetectionbetweenpatientsintheconventionalhepatectomy(5of21[24%])andanteriorapproach(6of22[27%])groups(P > .99).Exceptforalongeroperatingtimeintheanteriorapproachgroup(mean[SD],171[53]vs221[53]minutes;P .65betweenbothgroups,indicatingfutilityoftheassessmentofwhethertheanteriorapproachissuperiortoconventionalhepatectomyinreducingintraoperativetumorcelldisseminationinpatientsundergoingresectionofCRLM. DatawereanalyzedfromApril1toDecember1,2018,usingtheintention-to-treatpopulation.TheprimaryendpointwasanalyzedusingtheFisherexacttest.Categoricalvariableswereexpressedbyabsoluteandrelativefrequencies(percentage)andcomparedusingthePearsonχ2ortheFisherexacttest.Continuousvariablesweresummarizedasmean(SD)ormedian(interquartilerange[IQR]or95%CI)andcomparedusingtheunpaired2-tailedttestortheWilcoxonranksumtest,dependingonthepatternofdistribution.Analysesforoverallsurvivalanddisease-freesurvivalwereperformedusingtheKaplan-Meiermethodandthelog-ranktestbetweenthegroups.Patientswhoreachedthefinalpointoffollow-uporwhowerelosttofollow-upwerecensored.TheprognosticrelevanceoftumorcelldetectioninbonemarrowandbloodsampleswasassessedusingtheCoxproportionalhazardsregressionmethod.Thefollowingexplanatoryvariableswereincluded:clinicalriskscore,operatingtechnique,anddetectionofCTC.TheCochranQtestwasperformedtocorrelatetheRT-PCRresultswithtimingofbloodsampling,andtheMcNemartestwasconductedtocomparetumorcelldetectionratesinbloodvsbonemarrowsamples.Allstatisticaltestswereevaluatedforsignificanceat2-sidedP .99).Atotalof9of34patientsintheconventionalhepatectomygroup(26%)and12of38patientsintheanteriorapproachgroup(32%)haddisseminatedtumorcellsdetectedinthebonemarrowbeforesurgery(P = .80).Inlinewiththestudyprotocol,patientswithapositiveresectionmargin,excessiveintraoperativebloodloss,andpreoperativeCTCdetectionwereexcludedfromtheanalysisoftheprimaryendpoint.Afterexclusionofthesepatients,atotalof21patientsremainedintheconventionalhepatectomygroupand22remainedintheanteriorapproachgroupfortheanalysisoftheprimaryefficacyendpointofintraoperativedetectionofCK20-positiveCTC.QuizRefIDTheanalysisoftheprimaryendpointrevealednosignificantdifferenceinintraoperativeCTCdetectionbetweenbothgroups(5of21[24%]vs6of22[27%];P > .99)(Table3).Furtheranalysesshowednostatisticallysignificantdifferencesbetweenthetimingofbloodsamplinganddetectionoftumorcellsforallpatients(24of75[32%]forpreoperativevs21of73[29%]forintraoperative;P = .70)andforpatientsintheconventionalhepatectomy(12of37[32%]forpreoperativevs11of35[31%]forintraoperative;P > .99)oranteriorapproach(12of38[32%]forpreoperativevs10of38[26%]forintraoperative;P = .62)group(eTable1inSupplement2).Furthermore,therewasnostatisticallysignificantdifferenceinpreoperativedetectionofdisseminatedtumorcellsinbloodandbonemarrowsamplesoftherespectivepatients(13of21[62%]hadbothpositivetumorcellsdetectedinbloodandbonemarrowsamples,whereas8of21[38%]hadpositivetumorcellsdetectedinbloodbutnotumorcellsdetectedinbonemarrowsamples;P > .99)(eTable2inSupplement2). Long-termOutcomes Medianfollow-uptimewas46(IQR,0-116)monthsforthetotalcohort.Duringfollow-up,16patients(39%)intheconventionalhepatectomygroupand19patients(49%)intheanteriorapproachgroupdied.Therewasnosignificantdifferenceinmedianoverallsurvivalbetweenpatientsintheconventionalhepatectomygroup(73[95%CI,42-104]months)comparedwithpatientsintheanteriorapproachgroup(55[95%CI,35-75]months)(P = .43)(Figure2A). Onlastfollow-up,atotalof8patients(20%)intheconventionalhepatectomygroupand6patients(15%)intheanteriorapproachgroupshowednoevidenceofdisease(P = .47).Recurrenceofcolorectalcancerdevelopedin23patients(56%)intheconventionalhepatectomygroupandin17(44%)intheanteriorapproachgroup(P = .46).Themediandisease-freesurvivalwas48(95%CI,40-56)monthsintheconventionalhepatectomygroupand40(95%CI,28-52)monthsintheanteriorapproachgroup(P = .88)(Figure2B).Therewasnosignificantdifferenceinthepatternofdiseaserecurrencebetweenbothstudygroups.MostpatientswithrecurrentdiseasehadthefirstrecurrenceofCRLMwithintheliver(10[24%]intheconventionalhepatectomyvs8[21%]intheanteriorapproachgroups;P = .82).Althoughweobservedahigherincidenceofdiseaserecurrenceinthelungsinpatientsafterconventionalhepatectomy(n = 9)vsanteriorapproach(n = 5),thisdifferencedidnotreachstatisticalsignificance(P = .52).Fivepatientsintheconventionalhepatectomygroup(3 lung,1 liver,1 colon)and6patientsintheanteriorapproachgroup(2 liver,2 lung,1 bone,1 pelvis)underwentrepeatedmetastasectomyforrecurrentdisease.Chemotherapyforrecurrentdiseasewasadministeredinatotalof18patientsintheconventionalhepatectomyand12patientsintheanteriorapproachgroup.Overall,detectionofCTC(preoperativeandintraoperative)independentlyofthestudygroupwasassociatedwithsignificantlydecreasedoverallsurvival(median,46[95%CI,40-52]vs81[95%CI,54-107]months;P = .03)(Figure2C).Similarly,disease-freesurvivalwassignificantlyshorterinpatientswithpositiveCTCdetection(median,40[95%CI,34-46]vs60[95%CI,46-74]months;P = .04)(Figure2D).OnCoxproportionalhazardsregressionanalysis,detectionofpositiveCTCwasassociatedwithpoorsurvival(hazardratio,2.18;95%CI,1.09-4.37;P = .03)(eTable3inSupplement2). Discussion TheanteriorapproachtechniquewasfirstdescribedbyOzawa15in1992.Severalliversurgeonsadoptedthisapproachasano-touchtechniquewithouttumormanipulation,andrefinementsweremadebythehanginglivermaneuver.16Althoughthisapproachwasshowntobesafeandpotentiallysuperiortotheconventionalapproachintermsofmorbidity,survival,andCTCdisseminationinHCC,itsefficacyandsafetyforresectionofCRLMhasremainedunclear.11,12,17ThisrandomizedclinicaltrialaddressedthislackofevidenceusingintraoperativeCTCdetectionastheprimaryefficacyendpoint.Basedonanaprioriinterimanalysis,thetrialwasstoppedprematurely,andthenullhypothesiswasnotrejected.Intheentirecohort,however,CTCdetectionwasassociatedwithpooreroverallanddisease-freesurvival,whereasCTCdetectioninthestudygroupswascomparableandreflectedasimilaroncologicaloutcome.Perioperativeresultsrevealednosignificantdifferencesbetweenbothsurgicaltechniquesexceptforalongeroperatingtimeintheanteriorapproachgroup. DetectionofCTCisassociatedwithpooroutcomeinpatientswithprimaryaswellasmetastaticcolorectalcancer.6,7,18,19UsingtheUSFoodandDrugAdministration–approvedCellSearchdeviceforCTCdetectioninpatientswithcolorectalcancer,moreover,Rahbarietal8demonstratedtheabilityoflivermetastasestoshedintacttumorcellsintocirculation.Measurestolimitdetachmentoftumorcellsfrommetastaticlesionsarethereforeurgentlyneededtodecreasepotentialfurtherspreadoftumorcells.However,increasingdatasuggestthatCTCspontaneouslyleavingthecellularunionofatumormassarephenotypicallyandgenotypicallydifferentfromtumorcellsthataredetachedfromtheoriginalmasssecondarytomechanicalmanipulation.20-22AlthoughtheanteriorapproachfailedtoreducetheintraoperativeCTCdetectionrates,thesedatadonotsupportfurthereffortstoreducetumorcelldisseminationandsubsequentdiseaserecurrencebyminimizingintraoperativemanipulation.Theyshouldratherpromptstrategiestopreventspontaneoustumorcelldisseminationandtotargetminimalresidualdiseaseafterpotentiallycurativeresection. MostdataontheoncologicaleffectoftheanteriorapproachareavailableforpatientsundergoingresectionforHCC.ThefirstrandomizedclinicalstudyonthistopicbyLiuetal12analyzedpatientswithlargeHCC(>5cm)andrevealedasignificantoverallsurvivalbenefitaftertheanteriorapproach,whereasdisease-freesurvivalandperioperativeoutcomewerecomparablebetweenthestudygroups.Althoughtherecurrenceratewas56%inbothstudygroups,recurrentdiseasewasamenabletolocalablativeorsurgicaltherapyin80%ofpatientsaftertheanteriorapproachcomparedwith17%afterconventionalhepatectomy.Furthermore,theanteriorapproachwasassociatedwithintraoperativelowerplasmalevelsofalbuminmessengerRNA,supportingtheevidenceoflowerlevelsofcirculatinglivercellsduringtheanteriorapproach;however,CTCwerenotevaluated.AnotherrecentrandomizedclinicaltrialbyHaoetal11assessedpatientswithaheterogenoussizeofHCCanddetectedlessmeanandmedianepithelialcelladhesionmolecule–positiveCTCaftertheanteriorapproachcomparedwithconventionalhepatectomyinthefirst10postoperativedays.Unfortunately,long-termoutcomewasnotreported,but2-yearoverallandrecurrence-freesurvivalwassignificantlyreducedaftertheconventionalapproach.Thusfar,perioperativeoutcomeandlong-termsurvivalofpatientswithCRLMwhounderwentanteriorapproachandconventionalhepatectomywereonlyassessedin2nonrandomizedcohortstudies.23,24Finally,thesestudiesrevealednosignificantdifferencesbetweenthestudygroups,whichisconsistentwiththeresultsofthepresentstudy. Morbidityaftermajorhepatectomyremainshighandrangesfrom35%to69%dependingonthepatientpopulation,preexistingliverdisease,andvolumeofthefutureliverremnant.25-27Althoughtheanteriorapproachfailedtoprovideabenefitwithrespecttopatients’oncologicaloutcome,advantagesinperioperativeoutcomesmightstilljustifyitsuseinclinicalroutine.Ourresultsshowedasignificantlyprolongedoperatingtimeanddurationofportaltriadclampingforpatientsintheanteriorapproachgroupwithnostatisticallysignificantdifferenceinanyfurtherperioperativeparameters,includingbloodloss,morbidity,andlengthofhospitalstay.Thesedataareinlinewithpreviousdatafromrandomizedtrialsthatreportedsimilarperioperativeoutcomesforpatientswhounderwentaright-sidedhepatectomywiththeanteriorapproachandtheconventionalhepatectomyapproach.11,12,28Owingtothelackofbenefitsinperioperativeoutcomes,theanteriorapproachdoesnotappearsuperiortoconventionalhepatectomy.However,itisusefulinpatientswithlargemassesthatrenderprimarymobilizationoftherightlobedifficult.29PreviousstudiesonCTCdetectionusingCK20RT-PCRreportedhigherratesofCTC-positivefindings.30 WeusedahighlysensitiveandspecificRT-PCRassaytoidentifyCTCasdescribedandstandardizedpreviously.14,31Thenumberofpatientswithintraoperativepositivetumorcellswerecomparableinbothgroups.Intotal,wefoundaconsiderablylowerrateofCTCasdescribedintheliterature31,32;however,thiscouldbeowingtomodernchemotherapyprotocolswithsubsequentreductionoftumorcells. Limitations Ourstudyhassomelimitations.First,oursamplesizeisrelativelysmall,whichisprimarilyowingtoaprematureterminationofthestudy.Becausetherewerenostatisticallysignificantdifferencesfortheprimaryendpointoninterimanalysis,thestudywasdiscontinuedinlinewiththestudyprotocol.Second,8patientshadnobonemarrowsamplesbecauseofpatient’spreferencetoavoidanadditionalprocedure.Third,evaluationoftheprimaryendpointwaslimitedtoarelativelysmallgroupofpatientsowingtoahighnumberofpatientswithpreoperativepositivetumorcellsinbloodaswellasintraoperativebloodlossofmorethan2000mL,resultinginlossofstatisticalpowerandinconclusiveresults.Fourth,tominimizereportingbias,allpatientswereevaluatedforsecondaryoutcomes. Conclusions Inthisrandomizedclinicaltrial,patientsundergoingrighthepatectomyforcolorectalcancerbyanteriororconventionalresectionboreasimilarriskoftumorcelldissemination.Findingssuggestthatbothtechniquesaresafeandindicatenostatisticallysignificantdifferenceinpostoperativeoutcomeorlong-termsurvival. Backtotop ArticleInformation AcceptedforPublication:July30,2020.PublishedOnline:November4,2020.doi:10.1001/jamasurg.2020.5050Correction:ThisarticlewascorrectedonMay26,2021,tofixthePvalueforthedetectionofpreoperativeandintraoperativetumorcellsintheAbstract,maintext,andTable3,andtofixanerrorinthenumbersatriskinFigure2A.CorrespondingAuthor:JürgenWeitz,MD,DepartmentofGastrointestinal,ThoracicandVascularSurgery,UniversityHospitalCarlGustavCarusattheTechnischeUniversitätDresden,Fetscherstraße74,01307Dresden,Germany([email protected]).AuthorContributions:DrsRahbariandBirgincontributedequallytothisstudy.DrsRahbariandBirginhadfullaccesstoallthedatainthestudyandtakeresponsibilityfortheintegrityofthedataandtheaccuracyofthedataanalysis.Conceptanddesign:Weitz.Acquisition,analysis,orinterpretationofdata:Allauthors.Draftingofthemanuscript:Rahbari,Birgin.Criticalrevisionofthemanuscriptforimportantintellectualcontent:Allauthors.Statisticalanalysis:Rahbari,Birgin.Administrative,technical,ormaterialsupport:Bork,Mehrabi,Weitz.Supervision:Rahbari,Bork,Reißfelder.ConflictofInterestDisclosures:Nonereported.Funding/Support:ThisstudywassupportedbytheDepartmentofSurgery,UniversityofHeidelberg.RoleoftheFunder/Sponsor:Thesponsorhadnoroleinthedesignandconductofthestudy;interpretationofthedata;andpreparation,review,orapprovalofthemanuscript.Thesponsorwasinvolvedinthecollection,management,andanalysisofthedataandgrantedapprovaltosubmitthemanuscriptforpublication.DataSharingStatement:SeeSupplement3. References 1.Creasy JM,Sadot E,Koerkamp BG, etal. Actual10-yearsurvivalafterhepaticresectionofcolorectallivermetastases:whatfactorsprecludecure? Surgery.2018;163(6):1238-1244.doi:10.1016/j.surg.2018.01.004PubMedGoogleScholarCrossref2.deJong MC,Mayo SC,Pulitano C, etal. Repeatcurativeintentliversurgeryissafeandeffectiveforrecurrentcolorectallivermetastasis:resultsfromaninternationalmulti-institutionalanalysis. JGastrointestSurg.2009;13(12):2141-2151.doi:10.1007/s11605-009-1050-0PubMedGoogleScholarCrossref3.deJong MC,Pulitano C,Ribero D, etal. Ratesandpatternsofrecurrencefollowingcurativeintentsurgeryforcolorectallivermetastasis:aninternationalmulti-institutionalanalysisof1669patients. AnnSurg.2009;250(3):440-448.doi:10.1097/SLA.0b013e3181b4539bPubMedGoogleScholarCrossref4.Rahbari NN,D’Angelica MI. Surgicalsalvageofrecurrenceafterresectionofcolorectallivermetastases:incidenceandoutcomes. HepatOncol.2017;4(1):25-33.doi:10.2217/hep-2017-0002PubMedGoogleScholar5.Bork U,Rahbari NN,Schölch S, etal. Circulatingtumourcellsandoutcomeinnon-metastaticcolorectalcancer:aprospectivestudy. BrJCancer.2015;112(8):1306-1313.doi:10.1038/bjc.2015.88PubMedGoogleScholarCrossref6.GrootKoerkamp B,Rahbari NN,Büchler MW,Koch M,Weitz J. Circulatingtumorcellsandprognosisofpatientswithresectablecolorectallivermetastasesorwidespreadmetastaticcolorectalcancer:ameta-analysis. AnnSurgOncol.2013;20(7):2156-2165.doi:10.1245/s10434-013-2907-8PubMedGoogleScholarCrossref7.Rahbari NN,Aigner M,Thorlund K, etal. Meta-analysisshowsthatdetectionofcirculatingtumorcellsindicatespoorprognosisinpatientswithcolorectalcancer. Gastroenterology.2010;138(5):1714-1726.doi:10.1053/j.gastro.2010.01.008PubMedGoogleScholarCrossref8.Rahbari NN,Bork U,Schölch S, etal. Metastaticspreademergingfromlivermetastasesofcolorectalcancer:doestheseedleavethesoilagain? AnnSurg.2016;263(2):345-352.doi:10.1097/SLA.0000000000001341PubMedGoogleScholarCrossref9.Iwatsuki S,Esquivel CO,Gordon RD,Starzl TE. Liverresectionformetastaticcolorectalcancer. Surgery.1986;100(4):804-810.PubMedGoogleScholar10.Weitz J,Koch M,Kienle P, etal. Detectionofhematogenictumorcelldisseminationinpatientsundergoingresectionoflivermetastasesofcolorectalcancer. AnnSurg.2000;232(1):66-72.doi:10.1097/00000658-200007000-00010PubMedGoogleScholarCrossref11.Hao S,Chen S,Tu C,Huang T. AnteriorapproachtoimprovetheprognosisinHCCpatientsviadecreasingdisseminationofEpCAM+circulatingtumorcells. JGastrointestSurg.2017;21(7):1112-1120.doi:10.1007/s11605-017-3410-5PubMedGoogleScholarCrossref12.Liu CL,Fan ST,Cheung ST,Lo CM,Ng IO,Wong J. Anteriorapproachversusconventionalapproachrighthepaticresectionforlargehepatocellularcarcinoma:aprospectiverandomizedcontrolledstudy. AnnSurg.2006;244(2):194-203.doi:10.1097/01.sla.0000225095.18754.45PubMedGoogleScholarCrossref13.Schmidt T,Koch M,Antolovic D, etal. Influenceoftwodifferentresectiontechniques(conventionalliverresectionversusanteriorapproach)oflivermetastasesfromcolorectalcanceronhematogenoustumorcelldissemination:prospectiverandomizedmulticentertrial. BMCSurg.2008;8:6.doi:10.1186/1471-2482-8-6PubMedGoogleScholarCrossref14.Weitz J,Kienle P,Magener A, etal. Detectionofdisseminatedcolorectalcancercellsinlymphnodes,bloodandbonemarrow. ClinCancerRes.1999;5(7):1830-1836.PubMedGoogleScholar15.Ozawa K. NonconventionalApproachestoAdvancedLiverCancer:LiverSurgeryApproachedThroughtheMitochondria.MedicalTribune;1992:117-165.16.Liddo G,Buc E,Nagarajan G,Hidaka M,Dokmak S,Belghiti J. Theliverhangingmanoeuvre. HPB(Oxford).2009;11(4):296-305.doi:10.1111/j.1477-2574.2009.00068.xPubMedGoogleScholarCrossref17.Li Y,Xu KS,Li JS, etal. Theresearchofno-touchisolationtechniqueonthepreventionofpostoperativerecurrenceandmetastasisofhepatocellularcarcinomaafterhepatectomy. Hepatogastroenterology.2014;61(131):784-791.PubMedGoogleScholar18.Arrazubi V,Mata E,Antelo ML, etal. Circulatingtumorcellsinpatientsundergoingresectionofcolorectalcancerlivermetastases:clinicalutilityforlong-termoutcome:aprospectivetrial. AnnSurgOncol.2019;26(9):2805-2811.doi:10.1245/s10434-019-07503-8PubMedGoogleScholarCrossref19.Seeberg LT,Waage A,Brunborg C, etal. Circulatingtumorcellsinpatientswithcolorectallivermetastasispredictimpairedsurvival. AnnSurg.2015;261(1):164-171.doi:10.1097/SLA.0000000000000580PubMedGoogleScholarCrossref20.Gasch C,Bauernhofer T,Pichler M, etal. HeterogeneityofepidermalgrowthfactorreceptorstatusandmutationsofKRAS/PIK3CAincirculatingtumorcellsofpatientswithcolorectalcancer. ClinChem.2013;59(1):252-260.doi:10.1373/clinchem.2012.188557PubMedGoogleScholarCrossref21.Mostert B,Jiang Y,Sieuwerts AM, etal. KRASandBRAFmutationstatusincirculatingcolorectaltumorcellsandtheircorrelationwithprimaryandmetastatictumortissue. IntJCancer.2013;133(1):130-141.doi:10.1002/ijc.27987PubMedGoogleScholarCrossref22.Soler A,Cayrefourcq L,Mazard T, etal. Autologouscelllinesfromcirculatingcoloncancercellscapturedfromsequentialliquidbiopsiesasmodeltostudytherapy-driventumorchanges. SciRep.2018;8(1):15931.doi:10.1038/s41598-018-34365-zPubMedGoogleScholarCrossref23.She WH,Chan ACY,Ma KW, etal. Anteriorapproachtomajorresectionforcolorectallivermetastasis. JGastrointestSurg.2018;22(11):1928-1938.doi:10.1007/s11605-018-3840-8PubMedGoogleScholarCrossref24.Llado L,Muñoz A,Ramos E,Torras J,Fabregat J,Rafecas A. Theanteriorhanging-approachimprovespostoperativecourseafterrighthepatectomyinpatientswithcolorectallivermetastases:resultsofaprospectivestudywithpropensity-scorematchingcomparison. EurJSurgOncol.2016;42(2):176-183.doi:10.1016/j.ejso.2015.11.009PubMedGoogleScholarCrossref25.Fritzmann J,Kirchberg J,Sturm D, etal. RandomizedclinicaltrialofstaplerhepatectomyversusLigaSure™transectioninelectivehepaticresection. BrJSurg.2018;105(9):1119-1127.doi:10.1002/bjs.10902PubMedGoogleScholarCrossref26.Fretland AA,Dagenborg VJ,Bjørnelv GMW, etal. Laparoscopicversusopenresectionforcolorectallivermetastases:theOSLO-COMETrandomizedcontrolledtrial. AnnSurg.2018;267(2):199-207.doi:10.1097/SLA.0000000000002353PubMedGoogleScholarCrossref27.Schnitzbauer AA,Lang SA,Goessmann H, etal. Rightportalveinligationcombinedwithinsitusplittinginducesrapidleftlateralliverlobehypertrophyenabling2-stagedextendedrighthepaticresectioninsmall-for-sizesettings. AnnSurg.2012;255(3):405-414.doi:10.1097/SLA.0b013e31824856f5PubMedGoogleScholarCrossref28.Capussotti L,Ferrero A,Russolillo N,Langella S,LoTesoriere R,Viganò L. Routineanteriorapproachduringrighthepatectomy:resultsofaprospectiverandomisedcontrolledtrial. JGastrointestSurg.2012;16(7):1324-1332.doi:10.1007/s11605-012-1894-6PubMedGoogleScholarCrossref29.Coppa J,Citterio D,Cotsoglou C, etal. Transhepaticanteriorapproachtotheinferiorvenacavainlargeretroperitonealtumorsresectedenblocwiththerightliverlobe. Surgery.2013;154(5):1061-1068.doi:10.1016/j.surg.2013.05.027PubMedGoogleScholarCrossref30.Hinz S,Hendricks A,Wittig A, etal. DetectionofcirculatingtumorcellswithCK20RT-PCRisanindependentnegativeprognosticmarkerincoloncancerpatients:aprospectivestudy. BMCCancer.2017;17(1):53.doi:10.1186/s12885-016-3035-1PubMedGoogleScholarCrossref31.Koch M,Kienle P,Hinz U, etal. Detectionofhematogenoustumorcelldisseminationpredictstumorrelapseinpatientsundergoingsurgicalresectionofcolorectallivermetastases. AnnSurg.2005;241(2):199-205.doi:10.1097/01.sla.0000151795.15068.27PubMedGoogleScholarCrossref32.Soeth E,Vogel I,Röder C, etal. ComparativeanalysisofbonemarrowandvenousbloodisolatesfromgastrointestinalcancerpatientsforthedetectionofdisseminatedtumorcellsusingreversetranscriptionPCR. CancerRes.1997;57(15):3106-3110.PubMedGoogleScholar X . × Accessyoursubscriptions Signin|personalaccount Accessthroughyourinstitution Addorchangeinstitution Freeaccesstonewlypublishedarticles Createafreepersonalaccount Toregisterforemailalerts,accessfreePDF,andmore Purchaseaccess Subscribetojournal Getfulljournalaccessfor1year Buyarticle GetunlimitedaccessandaprintablePDF($40.00)— Signinorcreateafreeaccount Rentarticle RentthisarticlefromDeepDyve Accessyoursubscriptions Signin|personalaccount Accessthroughyourinstitution Addorchangeinstitution Freeaccesstonewlypublishedarticles Createafreepersonalaccount Toregisterforemailalerts,accessfreePDF,andmore Purchaseaccess Subscribetojournal Getfulljournalaccessfor1year Buyarticle GetunlimitedaccessandaprintablePDF($40.00)— Signinorcreateafreeaccount Rentarticle RentthisarticlefromDeepDyve SignintoaccessfreePDF Signin|personalaccount Accessthroughyourinstitution Addorchangeinstitution Freeaccesstonewlypublishedarticles Createafreepersonalaccount Toregisterforemailalerts,accessfreePDF,andmore Saveyoursearch Signin|personalaccount Freeaccesstonewlypublishedarticles Createafreepersonalaccount Toregisterforemailalerts,accessfreePDF,andmore Purchaseaccess Subscribenow Customizeyourinterests Signin|personalaccount Freeaccesstonewlypublishedarticles Createafreepersonalaccount Toregisterforemailalerts,accessfreePDF,andmore Createapersonalaccountorsigninto: Registerforemailalertswithlinkstofreefull-textarticles AccessPDFsoffreearticles Manageyourinterests Savesearchesandreceivesearchalerts PrivacyPolicy Makeacomment Signin|personalaccount Freeaccesstonewlypublishedarticles Createafreepersonalaccount Toregisterforemailalerts,accessfreePDF,andmore Createapersonalaccountorsigninto: Registerforemailalertswithlinkstofreefull-textarticles AccessPDFsoffreearticles Manageyourinterests Savesearchesandreceivesearchalerts PrivacyPolicy
延伸文章資訊
- 1Hepatectomy - Wikipedia
Hepatectomy is the surgical resection of the liver. While the term is often employed for the remo...
- 2Partial Hepatectomy - Moffitt Cancer Center
A partial hepatectomy, or liver resection, is a type of surgery designed to remove cancerous tumo...
- 3Anterior Approach vs Conventional Hepatectomy for ...
Importance Tumor relapse after partial hepatectomy for colorectal liver metastasis (CRLM) remains...
- 4Hepatectomy (Liver Resection) Surgery: Procedure & Recovery
- 5Management of post-hepatectomy complications - PMC - NCBI
Common post-hepatectomy complications include fever, hemorrhage, bile leakage, liver failure, ple...